nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—CALM1—cranial nerve—salivary gland cancer	0.031	0.118	CbGeAlD
Phenoxybenzamine—CALM2—ear—salivary gland cancer	0.0254	0.0963	CbGeAlD
Phenoxybenzamine—CALM1—ear—salivary gland cancer	0.0252	0.0958	CbGeAlD
Phenoxybenzamine—SLC22A3—tongue—salivary gland cancer	0.0184	0.0697	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—salivary gland cancer	0.00997	0.0378	CbGeAlD
Phenoxybenzamine—CALM3—parotid gland—salivary gland cancer	0.0093	0.0353	CbGeAlD
Phenoxybenzamine—CALM2—neck—salivary gland cancer	0.00897	0.0341	CbGeAlD
Phenoxybenzamine—CALM1—neck—salivary gland cancer	0.00893	0.0339	CbGeAlD
Phenoxybenzamine—CALM3—saliva-secreting gland—salivary gland cancer	0.00891	0.0338	CbGeAlD
Phenoxybenzamine—SLC22A3—parotid gland—salivary gland cancer	0.0086	0.0327	CbGeAlD
Phenoxybenzamine—SLC22A3—saliva-secreting gland—salivary gland cancer	0.00824	0.0313	CbGeAlD
Phenoxybenzamine—SLC22A3—connective tissue—salivary gland cancer	0.00757	0.0287	CbGeAlD
Phenoxybenzamine—CALM2—parotid gland—salivary gland cancer	0.0073	0.0277	CbGeAlD
Phenoxybenzamine—CALM2—saliva-secreting gland—salivary gland cancer	0.007	0.0266	CbGeAlD
Phenoxybenzamine—CALM1—saliva-secreting gland—salivary gland cancer	0.00696	0.0264	CbGeAlD
Phenoxybenzamine—ADRA2C—parotid gland—salivary gland cancer	0.00653	0.0248	CbGeAlD
Phenoxybenzamine—CALM2—connective tissue—salivary gland cancer	0.00643	0.0244	CbGeAlD
Phenoxybenzamine—CALM1—connective tissue—salivary gland cancer	0.0064	0.0243	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—salivary gland cancer	0.0061	0.0232	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—salivary gland cancer	0.00607	0.0231	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—salivary gland cancer	0.00572	0.0217	CbGeAlD
Phenoxybenzamine—CALM2—lymphoid tissue—salivary gland cancer	0.0047	0.0178	CbGeAlD
Phenoxybenzamine—CALM1—lymphoid tissue—salivary gland cancer	0.00468	0.0178	CbGeAlD
Phenoxybenzamine—ADRA2A—connective tissue—salivary gland cancer	0.00458	0.0174	CbGeAlD
Phenoxybenzamine—ADRA1A—lymphoid tissue—salivary gland cancer	0.00441	0.0167	CbGeAlD
Phenoxybenzamine—CALM3—lymph node—salivary gland cancer	0.00338	0.0128	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—salivary gland cancer	0.00312	0.0119	CbGeAlD
Phenoxybenzamine—CALM2—lymph node—salivary gland cancer	0.00265	0.0101	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—salivary gland cancer	0.00264	0.01	CbGeAlD
Phenoxybenzamine—ADRA2C—lymph node—salivary gland cancer	0.00237	0.009	CbGeAlD
Phenoxybenzamine—ADRA2A—lymph node—salivary gland cancer	0.00189	0.00718	CbGeAlD
Phenoxybenzamine—CALM2—Immune System—MAP2K2—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MAP2K2—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—EP300—salivary gland cancer	0.000121	0.000164	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—PIK3CA—salivary gland cancer	0.00012	0.000164	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.00012	0.000163	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—JAG1—salivary gland cancer	0.00012	0.000163	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FGFR4—salivary gland cancer	0.000119	0.000162	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—HRAS—salivary gland cancer	0.000119	0.000162	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FBXW7—salivary gland cancer	0.000117	0.000159	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FOXO3—salivary gland cancer	0.000117	0.000159	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000117	0.000159	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—EP300—salivary gland cancer	0.000117	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—EP300—salivary gland cancer	0.000117	0.000158	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—TP53—salivary gland cancer	0.000117	0.000158	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—JAG1—salivary gland cancer	0.000116	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—JAG1—salivary gland cancer	0.000116	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MAP2K2—salivary gland cancer	0.000115	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FGFR4—salivary gland cancer	0.000115	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FGFR4—salivary gland cancer	0.000115	0.000157	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MAP2K2—salivary gland cancer	0.000115	0.000157	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—PTEN—salivary gland cancer	0.000114	0.000155	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FBXW7—salivary gland cancer	0.000114	0.000154	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FBXW7—salivary gland cancer	0.000114	0.000154	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—PTEN—salivary gland cancer	0.000113	0.000154	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MAP2K2—salivary gland cancer	0.000112	0.000152	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MAP2K2—salivary gland cancer	0.000112	0.000152	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—HRAS—salivary gland cancer	0.000111	0.000151	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—PTEN—salivary gland cancer	0.00011	0.00015	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—PTEN—salivary gland cancer	0.00011	0.00015	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—PTEN—salivary gland cancer	0.000109	0.000149	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAP2K2—salivary gland cancer	0.000109	0.000148	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000109	0.000148	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—EP300—salivary gland cancer	0.000109	0.000147	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FOXO3—salivary gland cancer	0.000109	0.000147	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—EP300—salivary gland cancer	0.000108	0.000147	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000107	0.000146	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—NOTCH1—salivary gland cancer	0.000106	0.000144	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—PTEN—salivary gland cancer	0.000106	0.000144	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—PTEN—salivary gland cancer	0.000106	0.000144	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—EP300—salivary gland cancer	0.000105	0.000143	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—EP300—salivary gland cancer	0.000105	0.000143	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—CREBBP—salivary gland cancer	9.97e-05	0.000135	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FOXO3—salivary gland cancer	9.9e-05	0.000134	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—PIK3CA—salivary gland cancer	9.78e-05	0.000133	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—CREBBP—salivary gland cancer	9.69e-05	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CREBBP—salivary gland cancer	9.61e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FOXO3—salivary gland cancer	9.58e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FOXO3—salivary gland cancer	9.58e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—NOTCH1—salivary gland cancer	9.57e-05	0.00013	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAP2K2—salivary gland cancer	9.54e-05	0.000129	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TP53—salivary gland cancer	9.46e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—NOTCH1—salivary gland cancer	9.46e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—NOTCH1—salivary gland cancer	9.45e-05	0.000128	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CREBBP—salivary gland cancer	9.29e-05	0.000126	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—CREBBP—salivary gland cancer	9.29e-05	0.000126	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CDH1—salivary gland cancer	9.22e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—NOTCH1—salivary gland cancer	9.15e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—NOTCH1—salivary gland cancer	9.15e-05	0.000124	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—HRAS—salivary gland cancer	9.05e-05	0.000123	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—PIK3CA—salivary gland cancer	9.03e-05	0.000123	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CREBBP—salivary gland cancer	8.99e-05	0.000122	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CREBBP—salivary gland cancer	8.99e-05	0.000122	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NOTCH1—salivary gland cancer	8.94e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—PIK3CA—salivary gland cancer	8.93e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CDH1—salivary gland cancer	8.92e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CDH1—salivary gland cancer	8.92e-05	0.000121	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAP2K2—salivary gland cancer	8.86e-05	0.00012	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NOTCH1—salivary gland cancer	8.8e-05	0.000119	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CREBBP—salivary gland cancer	8.68e-05	0.000118	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NUP62—salivary gland cancer	8.65e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TP53—salivary gland cancer	8.64e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—PIK3CA—salivary gland cancer	8.63e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—PIK3CA—salivary gland cancer	8.63e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—VCAN—salivary gland cancer	8.58e-05	0.000117	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CREBBP—salivary gland cancer	8.58e-05	0.000116	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CREBBP—salivary gland cancer	8.57e-05	0.000116	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TP53—salivary gland cancer	8.35e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TP53—salivary gland cancer	8.35e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CREBBP—salivary gland cancer	8.3e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CREBBP—salivary gland cancer	8.3e-05	0.000113	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—HRAS—salivary gland cancer	8.26e-05	0.000112	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—PIK3CA—salivary gland cancer	8.2e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.15e-05	0.000111	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CREBBP—salivary gland cancer	8.1e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAP2K2—salivary gland cancer	8.09e-05	0.00011	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—PIK3CA—salivary gland cancer	8.04e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—PIK3CA—salivary gland cancer	8.04e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—PIK3CA—salivary gland cancer	8e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—HRAS—salivary gland cancer	7.99e-05	0.000108	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—HRAS—salivary gland cancer	7.99e-05	0.000108	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CREBBP—salivary gland cancer	7.98e-05	0.000108	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—CREBBP—salivary gland cancer	7.87e-05	0.000107	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAP2K2—salivary gland cancer	7.82e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAP2K2—salivary gland cancer	7.82e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NOTCH1—salivary gland cancer	7.81e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—PIK3CA—salivary gland cancer	7.77e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—PIK3CA—salivary gland cancer	7.77e-05	0.000106	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—PIK3CA—salivary gland cancer	7.72e-05	0.000105	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.61e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—HRAS—salivary gland cancer	7.58e-05	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—PIK3CA—salivary gland cancer	7.49e-05	0.000102	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—PIK3CA—salivary gland cancer	7.46e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—PIK3CA—salivary gland cancer	7.46e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—HRAS—salivary gland cancer	7.43e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—PIK3CA—salivary gland cancer	7.4e-05	0.0001	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—PIK3CA—salivary gland cancer	7.31e-05	9.92e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NOTCH1—salivary gland cancer	7.26e-05	9.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—HRAS—salivary gland cancer	7.19e-05	9.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—HRAS—salivary gland cancer	7.19e-05	9.76e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—CREBBP—salivary gland cancer	7.18e-05	9.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—HRAS—salivary gland cancer	7.14e-05	9.69e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PTEN—salivary gland cancer	7.12e-05	9.66e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCND1—salivary gland cancer	7.11e-05	9.65e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CREBBP—salivary gland cancer	7.08e-05	9.62e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—CREBBP—salivary gland cancer	6.95e-05	9.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—CREBBP—salivary gland cancer	6.95e-05	9.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PTEN—salivary gland cancer	6.92e-05	9.4e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—PIK3CA—salivary gland cancer	6.91e-05	9.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—HRAS—salivary gland cancer	6.91e-05	9.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—HRAS—salivary gland cancer	6.91e-05	9.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PTEN—salivary gland cancer	6.86e-05	9.32e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—HRAS—salivary gland cancer	6.85e-05	9.29e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—PIK3CA—salivary gland cancer	6.8e-05	9.24e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—EP300—salivary gland cancer	6.79e-05	9.21e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—HRAS—salivary gland cancer	6.76e-05	9.18e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—PIK3CA—salivary gland cancer	6.65e-05	9.03e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PTEN—salivary gland cancer	6.63e-05	9.01e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTEN—salivary gland cancer	6.63e-05	9.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NOTCH1—salivary gland cancer	6.62e-05	8.99e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—EP300—salivary gland cancer	6.6e-05	8.96e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CREBBP—salivary gland cancer	6.58e-05	8.94e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—EP300—salivary gland cancer	6.55e-05	8.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCND1—salivary gland cancer	6.42e-05	8.72e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PTEN—salivary gland cancer	6.42e-05	8.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PTEN—salivary gland cancer	6.42e-05	8.71e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NOTCH1—salivary gland cancer	6.41e-05	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NOTCH1—salivary gland cancer	6.41e-05	8.7e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—HRAS—salivary gland cancer	6.39e-05	8.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCND1—salivary gland cancer	6.34e-05	8.6e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—EP300—salivary gland cancer	6.33e-05	8.59e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—EP300—salivary gland cancer	6.33e-05	8.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—HRAS—salivary gland cancer	6.29e-05	8.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PTEN—salivary gland cancer	6.2e-05	8.41e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	6.18e-05	8.39e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTEN—salivary gland cancer	6.13e-05	8.32e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—EP300—salivary gland cancer	6.12e-05	8.31e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—EP300—salivary gland cancer	6.12e-05	8.31e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PTEN—salivary gland cancer	6.12e-05	8.3e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—PIK3CA—salivary gland cancer	6.04e-05	8.2e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CREBBP—salivary gland cancer	6.01e-05	8.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCND1—salivary gland cancer	6e-05	8.14e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTEN—salivary gland cancer	5.93e-05	8.04e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTEN—salivary gland cancer	5.93e-05	8.04e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EP300—salivary gland cancer	5.91e-05	8.02e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCND1—salivary gland cancer	5.9e-05	8.01e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EP300—salivary gland cancer	5.84e-05	7.93e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EP300—salivary gland cancer	5.83e-05	7.92e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CREBBP—salivary gland cancer	5.81e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CREBBP—salivary gland cancer	5.81e-05	7.89e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PTEN—salivary gland cancer	5.79e-05	7.86e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PTEN—salivary gland cancer	5.7e-05	7.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EP300—salivary gland cancer	5.65e-05	7.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EP300—salivary gland cancer	5.65e-05	7.67e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTEN—salivary gland cancer	5.62e-05	7.63e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—PIK3CA—salivary gland cancer	5.61e-05	7.62e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—HRAS—salivary gland cancer	5.59e-05	7.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EP300—salivary gland cancer	5.52e-05	7.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EP300—salivary gland cancer	5.43e-05	7.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—EP300—salivary gland cancer	5.36e-05	7.28e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCND1—salivary gland cancer	5.24e-05	7.12e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—salivary gland cancer	5.19e-05	7.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTEN—salivary gland cancer	5.13e-05	6.96e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—PIK3CA—salivary gland cancer	5.12e-05	6.95e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTEN—salivary gland cancer	5.06e-05	6.87e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PIK3CA—salivary gland cancer	5.02e-05	6.82e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTEN—salivary gland cancer	4.96e-05	6.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTEN—salivary gland cancer	4.96e-05	6.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PIK3CA—salivary gland cancer	4.96e-05	6.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PIK3CA—salivary gland cancer	4.96e-05	6.73e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—EP300—salivary gland cancer	4.89e-05	6.64e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PIK3CA—salivary gland cancer	4.88e-05	6.63e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCND1—salivary gland cancer	4.87e-05	6.61e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PIK3CA—salivary gland cancer	4.84e-05	6.57e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EP300—salivary gland cancer	4.83e-05	6.55e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—salivary gland cancer	4.74e-05	6.43e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—EP300—salivary gland cancer	4.73e-05	6.42e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—EP300—salivary gland cancer	4.73e-05	6.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTEN—salivary gland cancer	4.7e-05	6.38e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—salivary gland cancer	4.68e-05	6.36e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PIK3CA—salivary gland cancer	4.68e-05	6.35e-05	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PIK3CA—salivary gland cancer	4.68e-05	6.35e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—salivary gland cancer	4.58e-05	6.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—salivary gland cancer	4.58e-05	6.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PIK3CA—salivary gland cancer	4.53e-05	6.15e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PIK3CA—salivary gland cancer	4.53e-05	6.15e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EP300—salivary gland cancer	4.48e-05	6.09e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—salivary gland cancer	4.48e-05	6.08e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCND1—salivary gland cancer	4.44e-05	6.03e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PIK3CA—salivary gland cancer	4.37e-05	5.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—salivary gland cancer	4.33e-05	5.88e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PIK3CA—salivary gland cancer	4.32e-05	5.87e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PIK3CA—salivary gland cancer	4.32e-05	5.86e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCND1—salivary gland cancer	4.3e-05	5.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCND1—salivary gland cancer	4.3e-05	5.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTEN—salivary gland cancer	4.29e-05	5.82e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—salivary gland cancer	4.23e-05	5.74e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—salivary gland cancer	4.19e-05	5.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—salivary gland cancer	4.19e-05	5.69e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PIK3CA—salivary gland cancer	4.18e-05	5.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PIK3CA—salivary gland cancer	4.18e-05	5.68e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—salivary gland cancer	4.17e-05	5.67e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTEN—salivary gland cancer	4.15e-05	5.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTEN—salivary gland cancer	4.15e-05	5.63e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EP300—salivary gland cancer	4.09e-05	5.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PIK3CA—salivary gland cancer	4.08e-05	5.54e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—salivary gland cancer	4.04e-05	5.49e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PIK3CA—salivary gland cancer	4.02e-05	5.46e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—salivary gland cancer	4e-05	5.43e-05	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—salivary gland cancer	3.99e-05	5.42e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PIK3CA—salivary gland cancer	3.97e-05	5.38e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EP300—salivary gland cancer	3.96e-05	5.37e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EP300—salivary gland cancer	3.96e-05	5.37e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—salivary gland cancer	3.95e-05	5.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—salivary gland cancer	3.89e-05	5.28e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—salivary gland cancer	3.87e-05	5.25e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—salivary gland cancer	3.87e-05	5.25e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—salivary gland cancer	3.78e-05	5.13e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—salivary gland cancer	3.72e-05	5.05e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PIK3CA—salivary gland cancer	3.62e-05	4.91e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PIK3CA—salivary gland cancer	3.57e-05	4.85e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PIK3CA—salivary gland cancer	3.5e-05	4.75e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PIK3CA—salivary gland cancer	3.5e-05	4.75e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—salivary gland cancer	3.45e-05	4.69e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.35e-05	4.55e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PIK3CA—salivary gland cancer	3.32e-05	4.5e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—salivary gland cancer	3.3e-05	4.48e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—salivary gland cancer	3.21e-05	4.36e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—salivary gland cancer	3.07e-05	4.17e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CA—salivary gland cancer	3.03e-05	4.11e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—salivary gland cancer	2.93e-05	3.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CA—salivary gland cancer	2.93e-05	3.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CA—salivary gland cancer	2.93e-05	3.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—salivary gland cancer	2.83e-05	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—salivary gland cancer	2.83e-05	3.84e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—salivary gland cancer	2.8e-05	3.8e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—salivary gland cancer	2.71e-05	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—salivary gland cancer	2.71e-05	3.68e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.4e-05	3.25e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—EP300—salivary gland cancer	2.28e-05	3.1e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.69e-05	2.29e-05	CbGpPWpGaD
